![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2016
Reuther, Clemens; Heinzle, Vera; Spampatti, Matilde; Vlotides, George; De Toni, Enrico; Spöttl, Gerald; Maurer, Julian; Nölting, Svenja; Göke, Burkhard und Auernhammer, Christoph J.
(2016):
Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition.
In: Neuroendocrinology, Bd. 103, Nr. 3-4: S. 383-401
[PDF, 916kB]
2014
Nölting, Svenja; Giubellino, Alessio; Tayem, Yasin; Young, Karen; Lauseker, Michael; Bullova, Petra; Schovanek, Jan; Anver, Miriam; Fliedner, Stephanie; Korbonits, Marta; Göke, Burkhard; Vlotides, George; Grossman, Ashley und Pacak, Karel
(Juli 2014):
Combination of 13-Cis Retinoic Acid and Lovastatin: Marked Antitumor Potential In Vivo in a Pheochromocytoma Allograft Model in Female Athymic Nude Mice.
In: Endocrinology, Bd. 155, Nr. 7: S. 2377-2390
2013
Zitzmann, Kathrin; Andersen, Sandra; Vlotides, George; Spoettl, Gerald; Zhang, Shengwen; Datta, Rakesh; Culler, Michael; Göke, Burkhard und Auernhammer, Christoph J.
(2013):
The Novel Somatostatin Receptor 2/Dopamine Type 2 Receptor Chimeric Compound BIM-23A758 Decreases the Viability of Human GOT1 Midgut Carcinoid Cells.
In: Neuroendocrinology, Nr. 2: S. 128-136
[PDF, 782kB]